SCHEMBL21276813

SCHEMBL21276813

CNc1ccc(C#Cc2cnc3cc(OCCCN4CCOCC4)cnn23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.44
▸ HRH3 Q9Y5N1 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ HTR2A P28223 1/20 0.44
▸ SCN1A P35498 1/20 0.44
▸ HTR2B P41595 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ SCN2A Q99250 1/20 0.44
▸ SIGMAR1 Q99720 1/20 0.44
▸ SCN3A Q9NY46 1/20 0.44
▸ USP2 O75604 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HRH2 P25021 1/20 0.42
▸ HRH1 P35367 1/20 0.42
▸ EPHX2 P34913 5/20 0.41
▸ MAP2K1 Q02750 2/20 0.40
▸ RAF1 P04049 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21276713 0.89 HRH3 (0.42) MAPK1HRH3ALDH1A1CYP1A2CHRM2
SCHEMBL21276712 0.84 ACACB (0.41) HRH3ALDH1A1CYP1A2HRH2HRH1
SCHEMBL17447637 0.81 RET (0.60) KDR
SCHEMBL17447611 0.77 RET (0.59) KDR
SCHEMBL21276751 0.77 HRH3 (0.54) MAPK1HRH3ALDH1A1CYP1A2CHRM2
SCHEMBL21276831 0.74 MAP2K1 (0.40) MAPK1HRH3ALDH1A1CYP1A2CHRM2
SCHEMBL21276746 0.74 TSHR (0.51) MAPK1HRH3ALDH1A1CYP1A2CHRM2
SCHEMBL113405 0.70 LTA4H (0.63) MAPK1HRH3ALDH1A1CYP1A2CHRM2
SCHEMBL22747642 0.70 NPC1 (0.49) MAPK1HRH3ALDH1A1CYP1A2CHRM2
SCHEMBL18763485 0.70 RET (0.41) MAPK1HRH3ALDH1A1CYP1A2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169671-B1 1-(5-(TERT.-BUTYL)ISOXAZOL-3-YL)-3-(4-((PHENYL)ETHYNYL)PHENYL)UREA DERIVATIVES AND RELATED COMPOUNDS AS FLT3 INHIBITORS FOR TREATING CANCER SUNSHINE LAKE PHARMA CO LTD (CN) 2019-08-21 — — EP disclosed
Send feedback